Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Formaldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde induces the drug-metabolizing activity of DME CBS |
[1] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
1-nitropyrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00893
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
1-nitropyrene up-regulates the expression of DME CBS |
[2] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
1-methyl-4-phenylpyridinium |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01103
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Health Hazard |
DME Modulation |
1-methyl-4-phenylpyridinium induces the drug-metabolizing activity of DME CBS |
[3] |
Tris(1,3-dichloro-2-propyl)phosphate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01031
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Health Hazard |
DME Modulation |
Tris(1,3-dichloro-2-propyl)phosphate induces the drug-metabolizing activity of DME CBS |
[4] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Tobacco smoke pollution inhibits the expression of DME CBS |
[5] |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
BDE-99 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00925
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
BDE-99 up-regulates the expression of DME CBS |
[6] |
Tunicamycin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01494
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Tunicamycin A up-regulates the expression of DME CBS |
[7] |
Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Plant extracts |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01574
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Plant Extract |
DME Modulation |
Plant extracts inhibits the expression of DME CBS |
[8], [9] |
Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Jinfukang |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Traditional Medicine |
DME Modulation |
Jinfukang up-regulates the expression of DME CBS |
[10] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 10 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME CBS |
[11] |
Avobenzone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00411
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Avobenzone inhibits the expression of DME CBS |
[12] |
Cisplatin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin up-regulates the expression of DME CBS |
[13] |
Copper sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate up-regulates the expression of DME CBS |
[14] |
Cyclosporine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine up-regulates the expression of DME CBS |
[15] |
Hydroquinone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00430
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Hydroquinone up-regulates the expression of DME CBS |
[16] |
Indomethacin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00047
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Indomethacin up-regulates the expression of DME CBS |
[17] |
Tretinoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin inhibits the expression of DME CBS |
[18], [19] |
Valproic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid up-regulates the expression of DME CBS |
[20] |
Rotenone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00481
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Rotenone up-regulates the expression of DME CBS |
[21] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME CBS |
[22] |
Ethanol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Ethanol inhibits the expression of DME CBS |
[23] |
MS-275 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MS-275 up-regulates the expression of DME CBS |
[24] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Dihydrotestosterone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00536
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Dihydrotestosterone inhibits the drug-metabolizing activity of DME CBS |
[25] |
Sodium arsenite |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite inhibits the expression of DME CBS |
[26] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 inhibits the expression of DME CBS |
[27], [28] |
ICG-001 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
ICG-001 up-regulates the expression of DME CBS |
[29] |
K-7174 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 up-regulates the expression of DME CBS |
[30] |
|
|
|
|
|
|